LungSight™
AI powered CT Lung Cancer Screening Solution
Overview
Low-Dose Computed Tomography (LDCT) is a proven imaging technique for early detection of lung cancer, particularly in high-risk populations such as long-term smokers. By using lower radiation doses than standard CT scans, LDCT enables safe, repeatable annual screening without compromising diagnostic quality.
LungSight™ is a cutting-edge AI solution for lung cancer
detection through CT scans. It excels in early detection of pulmonary nodules, small, often asymptomatic lung lesions is critical, as lung cancer survival rates dramatically improve when diagnosed at an early stage. LDCT screening programs, guided by international protocols such as Lung-RADS (Lung Imaging Reporting and Data System), standardize interpretation and follow-up recommendations to reduce false positives and improve patient outcomes.
Key Features
- Automatically detect and segment pulmonary nodules with high sensitivity, including in challenging cases involving small or low-contrast lesions, to facilitate timely diagnosis and early intervention.
- Classify nodules according to Lung-RADS® categories (1–4X) in alignment with established clinical guidelines, ensuring standardized and reproducible reporting.
- Provide precise quantification of nodule dimensions, volumetric measurements, and growth rates to enable accurate longitudinal assessment.
- Optimize radiologist efficiency by prioritizing studies with suspicious findings and reducing false positives through advanced AI-driven filtering algorithms.
- Deliver integrated reporting with automated summarization of key findings, streamlining workflow and supporting rapid, evidence-based clinical decision-making.
Key Benefits
- Supports large-scale screening programs with consistent, reproducible results.
- Enhances radiologist productivity and diagnostic confidence.
- Improves patient outcomes through earlier detection and treatment planning.